Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeBoP trial in diabetic foot osteomyelitis
NL-OMON52791Completed
- Sponsor
- Vrije University Medical Center
- Start
- Feb 2019
- Countries
- 1
01
Overview
Randomised, open-label trial in diabetic foot osteomyelitis (DFO) (3 arms), sponsored by Vrije University Medical Center. Primary endpoint: Remission of osteomyelitis at 12 months. Started Feb 2019; status: completed.
02
Conditions
diabetic foot osteomyelitis (DFO)
Beyond the preview
Go deeper on NL-OMON52791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52791.